The GH-elevating effects of Tesamorelin work best when cortisol is managed, since cortisol directly opposes growth hormones anabolic actions
However, 6 of the 12 admitted patients were exposed to supratherapeutic doses, while 4 patients reportedly injected therapeutic doses
Patient characteristics such as poorer blood glucose control, higher body mass, and shorter duration of diabetes predict better response to medications that target the GLP-1 pathway
After completing their program, many patients have been able to stop taking their high blood pressure, cholesterol, and diabetes medicines
Myth #5: GLP-1 agonists are unsafe with numerous side effects Concerns about the safety of GLP-1 agonists and their potential side effects are common, leading some people to avoid these treatments altogether